DOC PREVIEW
UW-Madison BME 200 - Glaucoma Medication Reminder

This preview shows page 1-2-21-22 out of 22 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

BME Design 200/300Intellectual PropertyTeam InfoOverviewProblem StatementMotivationGlaucoma BackgroundSymptomsSpecificationsCurrent TechnologyDesign Idea 1: LCD SystemLCD System (Advantages and Disadvantages)LCD System (Materials and Costs)Design Idea 2: Modified PDAModified PDA (Advantages and Disadvantages)Modified PDA (Materials and Costs)Design Idea 3: Modified Egg TimerModified Egg Timer (Advantages and Disadvantages)Modified Egg Timer (Materials and Costs)Design MatrixFinal Design: Modified Egg TimerFuture WorkBME Design 200/300BME Design 200/300Glaucoma Medication ReminderIntellectual PropertyIntellectual PropertyAll information provided by individuals or Design Project Groups during All information provided by individuals or Design Project Groups during this or subsequent presentations is the property of the University and of this or subsequent presentations is the property of the University and of the researchers presenting this information. In addition, any information the researchers presenting this information. In addition, any information provided herein may include results sponsored by and provided to a provided herein may include results sponsored by and provided to a member company of the Biomedical Engineering Student Design member company of the Biomedical Engineering Student Design Consortium (SDC). The above information may include intellectual Consortium (SDC). The above information may include intellectual property rights belonging to the University to which the SDC may have property rights belonging to the University to which the SDC may have license rights. license rights. Anyone to whom this information is disclosed: Anyone to whom this information is disclosed: 1) Agrees to use this information solely for purposes related to this review;1) Agrees to use this information solely for purposes related to this review;2) Agrees not to use this information for any other purpose unless 2) Agrees not to use this information for any other purpose unless approved in advance by the Project Group, the Client / SDC, and the approved in advance by the Project Group, the Client / SDC, and the Advisor;Advisor;3) Agrees to keep this information in confidence until the University and 3) Agrees to keep this information in confidence until the University and the relevant parties listed in Part (2) above have evaluated and secured any the relevant parties listed in Part (2) above have evaluated and secured any applicable intellectual property rights in this information;applicable intellectual property rights in this information;4) Acknowledges that worldwide patent rights are waived if publication or 4) Acknowledges that worldwide patent rights are waived if publication or public dissemination occur prior to filing a corresponding U.S. provisional public dissemination occur prior to filing a corresponding U.S. provisional or utility patent application. or utility patent application.Team InfoTeam InfoMembersMembersChris WebsterChris WebsterMike Oldenburg Mike Oldenburg Ksenija BujanovicKsenija BujanovicJessica HauseJessica HauseAdvisorAdvisorDr. John WebsterDr. John WebsterProfessor, Biomedical Engineering DeptProfessor, Biomedical Engineering DeptClientsClientsLeo WangLeo WangOphthalmologistOphthalmologistPaul KauffmanPaul KauffmanChairman of Ophthalmology DepartmentChairman of Ophthalmology DepartmentOverviewOverviewProblem StatementProblem StatementMotivationMotivationBackground/SymptomsBackground/SymptomsSpecificationsSpecificationsCurrent TechnologyCurrent TechnologyThree Design IdeasThree Design IdeasDesign MatrixDesign MatrixFinal DesignFinal DesignFuture WorkFuture WorkProblem StatementProblem StatementDevelop a portable device to alert glaucoma Develop a portable device to alert glaucoma patients to take their next medicine. patients to take their next medicine. Patients are severely sight-impaired so an audio Patients are severely sight-impaired so an audio signal will be necessary. signal will be necessary. The device needs to be programmable for six The device needs to be programmable for six different medications. different medications. Reset mechanism, types of reminder signals, Reset mechanism, types of reminder signals, durability/portability, and power options must be durability/portability, and power options must be taken into consideration.taken into consideration.MotivationMotivationTo make it as easy as possible for To make it as easy as possible for patients to remember to take patients to remember to take medicationsmedicationsTo help prevent potential blindness To help prevent potential blindness caused by noncompliance to the caused by noncompliance to the medicationsmedicationsGlaucoma BackgroundGlaucoma BackgroundCauses blindnessCauses blindnessOcular pressure build upOcular pressure build upCrushes the optic nerveCrushes the optic nerveIf untreated, blindness may If untreated, blindness may result in a few yearsresult in a few yearsSymptoms Symptoms Usually no pain or symptoms from Usually no pain or symptoms from pressurepressurePeripheral vision is first to deteriorate Peripheral vision is first to deteriorate Can go unnoticed until late stagesCan go unnoticed until late stagesCannot be prevented or cured, but can be Cannot be prevented or cured, but can be controlled controlledSpecificationsSpecificationsRemind patients Remind patients when each when each medication should be medication should be takentakenAlarm with volume Alarm with volume controlcontrolClock with current Clock with current time for schedulingtime for schedulingAble to remind for up Able to remind for up to six different to six different medicationsmedicationsDigital screen with Digital screen with big, bold, black big, bold, black characterscharactersProgrammable by Programmable by physician with a physician with a locking mechanismlocking mechanismDurableDurableEstimated Size - 5Estimated Size - 5½’’ ½’’ x 2¾’’ x ¼ - ½’’x 2¾’’ x ¼ - ½’’Battery operatedBattery operatedCurrent TechnologyCurrent TechnologyMany on the marketMany on the marketWide range of costs, as Wide range of costs, as low as $20low as $20Portable, adjustable, Portable, adjustable, found in local drug storefound in local drug storeInsensitive to the sight Insensitive to the sight impaired or elderlyimpaired or


View Full Document

UW-Madison BME 200 - Glaucoma Medication Reminder

Documents in this Course
Load more
Download Glaucoma Medication Reminder
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view Glaucoma Medication Reminder and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view Glaucoma Medication Reminder 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?